CSIMarket
 


Natera inc   (NTRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

NTRA's Net Cash Flow Growth by Quarter and Year

Natera Inc 's Net Cash Flow results by quarter and year




NTRA Net Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December -26.62 408.96 -10.72 -13.79
III Quarter September 287.60 -34.26 32.29 21.68
II Quarter June -22.04 -67.14 -2.25 -33.24
I Quarter March -62.94 73.91 16.43 12.22
FY   176.01 381.47 35.75 -13.13



NTRA Net Cash Flow fourth quarter 2023 Y/Y Growth Comment
Natera inc in the fourth quarter 2023 recorded net cash outflow of $ -26.62 millions.

According to the results reported in the fourth quarter 2023, Natera Inc achieved the best Net Cash Flow growth in Medical Laboratories industry. While Natera Inc ' s Net Cash Flow no change of % ranks overall at the positon no. 291 in the fourth quarter 2023.




NTRA Net Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - 48.94 % -
II Quarter June - - - -
I Quarter March - 349.85 % 34.45 % -
FY   -53.86 % 967.05 % - -

Financial Statements
Natera Inc 's fourth quarter 2023 Net Cash Flow $ -26.62 millions NTRA's Income Statement
Natera Inc 's fourth quarter 2022 Net Cash Flow $ 408.96 millions Quarterly NTRA's Income Statement
New: More NTRA's historic Net Cash Flow Growth >>


NTRA Net Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - 11.29 %
FY (Year on Year)   -53.86 % 967.05 % - -




Net Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #1
Healthcare Sector #26
Overall #291

Net Cash Flow Y/Y Growth Statistics
High Average Low
966.8 % 284.27 % -216.86 %
(Dec 31 2022)   (Sep 30 2022)
Net Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #1
Healthcare Sector #26
Overall #291
Net Cash Flow Y/Y Growth Statistics
High Average Low
966.8 % 284.27 % -216.86 %
(Dec 31 2022)   (Sep 30 2022)

Net Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Natera Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NTRA's IV. Quarter Q/Q Net Cash Flow Comment
Recent net cash outflow of -26.62 millions by Natera inc look even worse considering the net cash outflow 287.60 millions a quarter before.

Within Medical Laboratories industry Natera inc achieved highest sequential Net Cash Flow growth. While Natera Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NTRA's IV. Quarter Q/Q Net Cash Flow Comment
Current accomplishment of -26.62 millions by Natera inc appear even less good compare to the net cash outflow 287.60 millions in the third quarter.

Within Medical Laboratories industry Natera inc achieved highest sequential Net Cash Flow growth. While Natera Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Natera Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Net Cash Flow 12 Months Ending $ 176.00 $ 611.58 $ 289.73 $ 244.63 $ 381.48
Y / Y Net Cash Flow Growth (TTM) -53.86 % - 922.15 % 162.37 % 966.8 %
Year on Year Net Cash Flow Growth Overall Ranking # 55 # 44 # 223 # 273 # 176
Seqeuential Net Cash Flow Change (TTM) -71.22 % 111.09 % 18.44 % -35.87 % -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 291 # 312 # 380 # 200 # 194




Cumulative Net Cash Flow growth Comment
Natera Inc showed decline, but improvement compare to trailing twelve month Net Cash Flow decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Natera Inc 's annual Net Cash Flow drop would be -53.86% year on year to $176 millions.

Among companies within the Healthcare sector 4 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Net Cash Flow growth total ranking has deteriorated compare to previous quarter from 44 to 55.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
966.8 %
284.27 %
-216.86 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 1
Healthcare Sector # 5
Overall # 55

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
966.8 %
284.27 %
-216.86 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 26
S&P 500 # 291
Cumulative Net Cash Flow growth Comment
Natera Inc showed decline, but improvement compare to trailing twelve month Net Cash Flow decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Natera Inc 's annual Net Cash Flow drop would be -53.86% year on year to $176 millions.

Among companies within the Healthcare sector 4 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Net Cash Flow growth total ranking has deteriorated compare to previous quarter from 44 to 55.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
966.8 %
284.27 %
-216.86 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 1
Healthcare Sector # 5
Overall # 55

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
966.8 %
284.27 %
-216.86 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 26
S&P 500 # 291




Other Net Cash Flow Growth
Medical Laboratories Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
NTRA's Net Cash Flow Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for NTRA's Competitors
Net Cash Flow Growth for Natera Inc 's Suppliers
Net Cash Flow Growth for NTRA's Customers

You may also want to know
NTRA's Annual Growth Rates NTRA's Profitability Ratios NTRA's Asset Turnover Ratio NTRA's Dividend Growth
NTRA's Roe NTRA's Valuation Ratios NTRA's Financial Strength Ratios NTRA's Dividend Payout Ratio
NTRA's Roa NTRA's Inventory Turnover Ratio NTRA's Growth Rates NTRA's Dividend Comparisons



Companies with similar Net Cash Flow drop for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Dec 31 2023
Astrazeneca Plc-5.29%$ -5.287 millions
Lipocine Inc -6.98%$ -6.984 millions
Caredx Inc -14.62%$ -14.617 millions
Sophia Genetics Sa-16.41%$ -16.406 millions
Xencor Inc-17.78%$ -17.780 millions
Kronos Bio Inc -20.78%$ -20.784 millions
Earth Science Tech Inc -21.38%$ -21.381 millions
Hookipa Pharma inc -22.19%$ -22.193 millions
Anaptysbio Inc -24.22%$ -24.222 millions
Aclarion Inc -24.38%$ -24.381 millions
Koru Medical Systems Inc-26.57%$ -26.570 millions
Abbott Laboratories-35.07%$ -35.069 millions
Lantheus Holdings Inc -37.16%$ -37.161 millions
Alcon inc -37.78%$ -37.778 millions
Inflarx N v -38.04%$ -38.037 millions
Novartis Ag-39.41%$ -39.413 millions
Argenx se-40.00%$ -40.005 millions
Gh Research Plc-40.04%$ -40.040 millions
Bright Minds Biosciences Inc -41.15%$ -41.154 millions
Enzon Pharmaceuticals inc -42.33%$ -42.332 millions
Myriad Genetics Inc -44.65%$ -44.653 millions
Elutia inc -46.46%$ -46.456 millions
Gilead Sciences Inc -46.70%$ -46.704 millions
Koninklijke Philips Nv-49.11%$ -49.110 millions
Avidity Biosciences Inc -49.45%$ -49.449 millions
Proqr Therapeutics N v -49.46%$ -49.460 millions
Protalix Biotherapeutics inc -49.52%$ -49.523 millions
Xeris Biopharma Holdings Inc -49.99%$ -49.994 millions
Altair International Corp -52.34%$ -52.344 millions
Psychemedics Corporation-54.02%$ -54.025 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com